Tech Times

Esbriet, Ofev Approved to Treat Deadly Lung Disease
U.S. News & World Report
THURSDAY, Oct. 16, 2014 (HealthDay News) -- Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF). Approval was ...
Health Highlights: Oct. 16,
Boehringer Ingelheim and InterMune IPF Drugs ApprovedMedPage Today
FDA Approves Two Drugs as First Treatments For Fatal Lung DiseaseHeadlines & Global News
FiercePharma -Daily Digest
all 132 news articles »